Search research articles
Contact Us
Filters
Showing results (61-70 of 152) with videos related to
Page
of 16
Sort By:
Diabetes Care
|
March 1, 2005
Cholestatic hepatitis associated with repaglinide
Francisco López-García, Joaquín Borrás, Clara Verdú, et al.
European Journal of Gastroenterology & Hepatology
|
January 14, 2005
The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment
M Isabel Lucena, Enrique López-Torres, Carmen Verge, et al.
Drug Safety
|
August 25, 2022
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
Hao Niu, Edmond Atallah, Ismael Alvarez-Alvarez, et al.
The Journal of Clinical Psychiatry
|
March 5, 2002
Hepatotoxicity associated with the new antidepressants
Alfonso Carvajal García-Pando, Javier García del Pozo, Ana Sánchez Sánchez, et al.
Drug Safety
|
May 22, 2010
Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work
Ayako Suzuki, Raul J Andrade, Einar Bjornsson, et al.
The European Journal of General Practice
|
December 15, 2025
Advancing clinical research in the Spanish primary care service: Challenges, opportunities, and lessons from other European models
Jose Cárdenas-Quesada, Ángela Remesal-Doblado, Vanesa Garrido-Rodríguez, et al.
European Journal of Gastroenterology & Hepatology
|
August 13, 2002
Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity
Raúl J Andrade, M Isabel Lucena, M Carmen Fernández, et al.
Expert Opinion on Drug Safety
|
August 19, 2016
Hepatotoxicity induced by coxibs: how concerned should we be?
Fernando Bessone, Nelia Hernandez, Marcelo Gabriel Roma, et al.
Journal of Clinical Medicine
|
November 27, 2021
Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions
Marina Villanueva-Paz, Hao Niu, Antonio Segovia-Zafra, et al.
Journal of Hepatology
|
April 12, 2021
Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI
Kristin Ashby, Wei Zhuang, Andres González-Jimenez, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 152) with videos related to
Sort By:
Page
of 16
Diabetes Care
|
March 1, 2005
Cholestatic hepatitis associated with repaglinide
Francisco López-García, Joaquín Borrás, Clara Verdú, et al.
European Journal of Gastroenterology & Hepatology
|
January 14, 2005
The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment
M Isabel Lucena, Enrique López-Torres, Carmen Verge, et al.
Drug Safety
|
August 25, 2022
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
Hao Niu, Edmond Atallah, Ismael Alvarez-Alvarez, et al.
The Journal of Clinical Psychiatry
|
March 5, 2002
Hepatotoxicity associated with the new antidepressants
Alfonso Carvajal García-Pando, Javier García del Pozo, Ana Sánchez Sánchez, et al.
Drug Safety
|
May 22, 2010
Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work
Ayako Suzuki, Raul J Andrade, Einar Bjornsson, et al.
The European Journal of General Practice
|
December 15, 2025
Advancing clinical research in the Spanish primary care service: Challenges, opportunities, and lessons from other European models
Jose Cárdenas-Quesada, Ángela Remesal-Doblado, Vanesa Garrido-Rodríguez, et al.
European Journal of Gastroenterology & Hepatology
|
August 13, 2002
Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity
Raúl J Andrade, M Isabel Lucena, M Carmen Fernández, et al.
Expert Opinion on Drug Safety
|
August 19, 2016
Hepatotoxicity induced by coxibs: how concerned should we be?
Fernando Bessone, Nelia Hernandez, Marcelo Gabriel Roma, et al.
Journal of Clinical Medicine
|
November 27, 2021
Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions
Marina Villanueva-Paz, Hao Niu, Antonio Segovia-Zafra, et al.
Journal of Hepatology
|
April 12, 2021
Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI
Kristin Ashby, Wei Zhuang, Andres González-Jimenez, et al.
Page
of 16